Orbimed Advisors LLC Insmed Inc Transaction History

Orbimed Advisors LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$13.63 - $33.98 $804,170 - $2 Million	-59,000 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$16.12 - $24.98 $8.11 Million - $12.6 Million	-503,300 Reduced 89.51%	59,000 $1.41 Million
Q3 2019 Nov 14, 2019	BUY	$15.49 - $25.78 $8.71 Million - $14.5 Million	562,300 New	562,300 $9.92 Million
Q4 2018 Feb 14, 2019	SELL	$11.6 - $18.7 $21.2 Million - $34.2 Million	-1,829,300 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$18.95 - $28.08 $20.8 Million - $30.8 Million	-1,098,591 Reduced 37.52%	1,829,300 $37 Million
Q1 2018 May 15, 2018	BUY	$21.69 - $32.99 $31 Million - $47.2 Million	1,431,100 Added 95.61%	2,927,891 $65.9 Million
Q4 2017 Feb 14, 2018	SELL	$26.43 - $31.78 $10 Million - $12 Million	-378,225 Reduced 20.17%	1,496,791 $46.7 Million
Q3 2017 Nov 14, 2017	BUY	$11.61 - $31.21 $21.8 Million - $58.5 Million	1,875,016	1,875,016 $58.5 Million

466

180M

2.27M

3.33M

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $9.4B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Orbimed Advisors LLC with notifications on news.